1. Home
  2. CGON vs EPC Comparison

CGON vs EPC Comparison

Compare CGON & EPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGON
  • EPC
  • Stock Information
  • Founded
  • CGON 2010
  • EPC 1999
  • Country
  • CGON United States
  • EPC United States
  • Employees
  • CGON N/A
  • EPC N/A
  • Industry
  • CGON
  • EPC Package Goods/Cosmetics
  • Sector
  • CGON
  • EPC Consumer Discretionary
  • Exchange
  • CGON NYSE
  • EPC Nasdaq
  • Market Cap
  • CGON 1.3B
  • EPC 1.4B
  • IPO Year
  • CGON 2024
  • EPC 2000
  • Fundamental
  • Price
  • CGON $25.62
  • EPC $27.61
  • Analyst Decision
  • CGON Strong Buy
  • EPC Buy
  • Analyst Count
  • CGON 10
  • EPC 7
  • Target Price
  • CGON $64.00
  • EPC $33.00
  • AVG Volume (30 Days)
  • CGON 1.4M
  • EPC 676.0K
  • Earning Date
  • CGON 05-13-2025
  • EPC 05-07-2025
  • Dividend Yield
  • CGON N/A
  • EPC 2.17%
  • EPS Growth
  • CGON N/A
  • EPC N/A
  • EPS
  • CGON N/A
  • EPC 1.72
  • Revenue
  • CGON $662,000.00
  • EPC $2,224,500,000.00
  • Revenue This Year
  • CGON N/A
  • EPC $0.86
  • Revenue Next Year
  • CGON $12,387.03
  • EPC $2.33
  • P/E Ratio
  • CGON N/A
  • EPC $16.09
  • Revenue Growth
  • CGON 224.51
  • EPC N/A
  • 52 Week Low
  • CGON $14.80
  • EPC $24.35
  • 52 Week High
  • CGON $40.47
  • EPC $41.50
  • Technical
  • Relative Strength Index (RSI)
  • CGON 53.27
  • EPC 41.76
  • Support Level
  • CGON $24.79
  • EPC $26.67
  • Resistance Level
  • CGON $26.60
  • EPC $28.28
  • Average True Range (ATR)
  • CGON 1.39
  • EPC 0.64
  • MACD
  • CGON -0.01
  • EPC 0.00
  • Stochastic Oscillator
  • CGON 48.52
  • EPC 41.78

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

About EPC Edgewell Personal Care Company

Edgewell Personal Care Co is a personal-care company. The operating segments of the company include Wet Shave, Sun and Skin Care and Feminine Care. Some of the brands offered by the company include Edge, Skintimate, Personna, Schick, Carefree, Playtex, Banana Boat and Hawaiian Tropic. It derives a majority of its revenue from the United States.

Share on Social Networks: